[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 17, Issue 1 (Bimonthly 2013) ::
Feyz 2013, 17(1): 1-7 Back to browse issues page
Evaluating the effect of HU-210 on cytokines profile and the clinical signs in the experimental model of multiple sclerosis
Mohammad Hossein Aarabi, Mohammad Esmaeel Shahaboddin *, Karim Parastouei, Mitra Motallebi, Akbar Jafarnejad, Sayyed Mahdi Mirhashemi, Gholam Ali Hamidi, Shokofeh Alvani
Kashan University of Medical Sciences , shahaboddin@kaums.ac.ir
Abstract:   (5514 Views)

Background: Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the CNS. Recent studies have described the anti-inflammatory and immunomodulatory properties of cannabinoids. One of the synthetic components that activate cannabinoid receptors is HU-210. This study aimed to examine the effect of HU-210 on cytokines profile and the clinical signs of the disease in the experimental autoimmune encephalomyelitis (EAE).

Materials and Methods: In this experimental study, 48 male C57BL/6 mice were immunized with 250 µg of myelin oligodendrocyte glycoprotein peptide (MOG35–55). Different doses of HU-210 (3¸10¸30 mg/kg, i.p.) were administered for 17 days (every other day) in the 3 groups of mice, respectively. The clinical status of mice during the study was evaluated using the clinical score tests. The animals were sacrificed at the 17th day of treatment and then the serum TNFα, IL-12 and IL-4 levels were measured using the ELISA method.

Results: Results showed that the HU-210-treated mice, especially with a dose of 30 mg/kg, had significantly less clinical score of EAE than the non-treated EAE-induced mice. The administration of HU-210 (30 mg/kg) in the EAE-induced mice significantly decreased the serum TNFα and IL-12 levels. Moreover, the serum IL-4 level was increased significantly in the mice treated with three doses of HU-210 (3, 10, 30 mg/kg) compared to those treated with phosphate.

Conclusion: HU-210, which triggers the stages of an immunological cascade, has a beneficial effect in the EAE. This drug can be used for the acute phase of MS.

Keywords: Multiple sclerosis, HU-210, Cytokines, Cannabinoids
Full-Text [PDF 286 kb]   (1532 Downloads)    
Type of Study: Research | Subject: medicine, paraclinic
Received: 2013/03/10 | Accepted: 2013/03/16 | Published: 2013/03/16
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Aarabi M H, Shahaboddin M E, Parastouei K, Motallebi M, Jafarnejad A, Mirhashemi S M, et al . Evaluating the effect of HU-210 on cytokines profile and the clinical signs in the experimental model of multiple sclerosis. Feyz. 2013; 17 (1) :1-7
URL: http://feyz.kaums.ac.ir/article-1-1872-en.html


Volume 17, Issue 1 (Bimonthly 2013) Back to browse issues page
مجله علمی پژوهشی فیض ::: دانشگاه علوم پزشکی کاشان KAUMS Journal ( FEYZ )
Persian site map - English site map - Created in 0.05 seconds with 32 queries by YEKTAWEB 3977